Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
07/2001
07/26/2001WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
07/26/2001WO1999015129A3 SELECTIVE cPLA2 INHIBITORS
07/26/2001US20010009915 Nitrogen oxide yielding and thromboxane A2 (TXA2) and serotonin (5HT2) receptor antagonist; treatment of atherothrombotic cardiovascular disorders
07/26/2001US20010009911 Isomers, hydrates, solvates and addition salts in treatment of endothelial dysfunction disease such as atherosclerosis, dyslipidaemia; antidiabetic agents; heart transplantation; inhibition of nitrogen monoxide synthase and oxidative stress
07/26/2001DE10002509A1 New substituted glutarimide derivatives are IL-12 antagonists, are useful as immunomodulators and for the treatment of angiopathy, hematological or oncological disorders
07/26/2001CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
07/26/2001CA2398061A1 Substituted glutarimides and their use as inhibitors of il-12 production
07/25/2001EP1118610A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
07/25/2001EP1118322A1 Drugs for improving vesical excretory strength
07/25/2001EP1117801A2 Polyketide synthase enzymes and recombinant dna constructs therefor
07/25/2001EP1117640A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
07/25/2001EP1117404A1 Composition for treatment of light-injured retinal degeneration disease
07/25/2001EP1117372A2 Method of treating hair loss using sulfonamides
07/25/2001EP1117371A2 Method of treating hair loss using ketoamides
07/25/2001EP0889876B1 Meta-substituted phenylene sulphonamide derivatives
07/25/2001CN1305454A Anthranilic acid derivatives as inhibitors of CGMP phosphodiesterase
07/25/2001CN1305453A Fluorovinyloxyacetamides, process for preparing the same and herbicidal composition comprising the same
07/25/2001CN1304930A Arylsulfurylisooximino acid derivative
07/25/2001CN1304929A 4-hydroxy-4-phenyl piperidine derivative and medicine containing said derivative
07/25/2001CN1068881C Phenyl-oxo-alkyl-(4-pieridinyl) benzoate derivs
07/25/2001CN1068880C N-substituted piperidingl bicyclic benzoate derivatives
07/24/2001US6265610 Contrast media for angiography
07/24/2001US6265433 LTA4 hydrolase inhibitors
07/24/2001US6265408 Sulphonamide derivatives and their use in the treatment of CNS disorders
07/24/2001US6265127 1, 4-dihydrophyridine charge control agents for electrostatographic toners and developers
07/24/2001CA2218503C Arylsulfonyl hydroxamic acid derivatives
07/24/2001CA2031588C Substituted cyclohexanols and cyclohexylamines as central nervous system agents
07/19/2001WO2001051479A2 Tricyclic compounds with antiviral activity
07/19/2001WO2001051474A2 Polypharmacophoric agents
07/19/2001WO2001051469A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists
07/19/2001WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
07/19/2001WO2001051456A2 Antibacterial agents
07/19/2001WO2001006261A3 Screening for therapeutic agents being scap antagonists
07/19/2001WO2001005762A3 Biphenyl derivatives, production thereof and use as mtp inhibitors
07/19/2001WO2001005392A3 Method for treating chronic pain using mek inhibitors
07/19/2001WO2001002345A3 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers
07/19/2001WO2000076970A3 Serine protease inhibitors
07/19/2001US20010008897 Carrying out the resolution of (+/-) E-2-(3,4-dichlorocinnamyl)piperidine via the eutomeric diastereoisomeric salt with N-acetyl-L-phenylalanine, acylating, reducing with cyclopropanecarbonyl chloride
07/19/2001CA2397575A1 Antibacterial agents
07/19/2001CA2396560A1 Tricyclic compounds and method of treating herpes virus
07/19/2001CA2396007A1 Piperidine and piperazine derivatives
07/19/2001CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases
07/18/2001EP1116716A1 Piperidine and piperazine compounds for use in the treatment of Alzheimer
07/18/2001EP1116711A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds
07/18/2001EP1115702A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof
07/18/2001EP1115697A1 Unsaturated hydroximic acid derivatives as parp inhibitors
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/17/2001US6262114 Leukotriene B4 antagonist compounds and method for treatment
07/17/2001US6262101 Alpha-pyrrolidine, imidazole and thiophene-substituted styrene derivatives; inhibitors of tumor necrosis factor alpha, nuclear factor kappa b, and phosphodiesterase
07/17/2001US6262092 Mutual salt of amlodipine and atorvastatin
07/17/2001US6262090 Aminopyridine-containing thiourea inhibitors of herpes viruses
07/17/2001US6262078 Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain
07/17/2001US6262066 High affinity ligands for nociceptin receptor ORL-1
07/17/2001US6262060 Treatment of hyperglycaemia, diabetes, obesity or inflammation
07/17/2001US6262046 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
07/12/2001WO2001049721A2 Bacterial genes and proteins that are essential for cell viability and their uses
07/12/2001WO2001049670A1 5,10-dihydroacridines as calcium channel blockers
07/12/2001WO2001049288A1 Novel compounds and compositions as protease inhibitors
07/12/2001WO2001004093A3 Process for producing paroxetine derivatives by mitsunobu reaction
07/12/2001WO2001002358A3 Cyclized amide derivatives for treating or preventing neuronal damage
07/12/2001US20010007680 Use of a film coating as taste-masking coating of oral dosage forms
07/12/2001DE19945351A1 Verfahren zum Auffinden und zur Isolierung pharmakologisch wirksamer Verbindungen aus Substanzgemischen sowie eine Vorrichtung zur Durchführung des Verfahrens A method for finding and isolating pharmacologically active compounds from substance mixtures, and an apparatus for carrying out the method
07/12/2001DE10000739A1 New piperidine and piperazine derivatives which are antagonists of certain serotonin receptors, are useful in treatment of, e.g. eating disorders, stroke, anxiety or Parkinson's disease
07/12/2001CA2396257A1 Novel compounds and compositions as protease inhibitors
07/12/2001CA2396040A1 Novel bacterial genes and proteins that are essential for cell viability and their uses
07/12/2001CA2394199A1 5,10-dihydroacridines as calcium channel blockers
07/11/2001EP1114823A2 Substituted benzylamino nitrogen containing non-aromatic heterocycles
07/11/2001EP1114817A1 Substituted benzylamino piperidine compounds
07/11/2001EP1114813A2 Method of stabilizing N-oxyl compounds in vinyl compounds
07/11/2001EP1114027A1 The preparation of n-substituted-hydroxycycloalkylamine derivatives
07/11/2001EP1114024A1 Urokinase inhibitors
07/11/2001EP0823896B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
07/11/2001CN1303378A 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for treatment of HIV related diseases
07/11/2001CN1303377A Amino piperidine derivatives as integrin alpha beta 3 antagonists
07/11/2001CN1303376A Compound with activity on muscarinic receptors
07/11/2001CN1303365A Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
07/11/2001CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity
07/10/2001US6258955 Process for preparing 2-piperidineethanol compounds
07/10/2001US6258953 Arylacrylamide derivatives
07/10/2001CA2069608C Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
07/05/2001WO2001047887A1 β-AMINO ACID COMPOUNDS AS INTEGRIN ANTAGONISTS
07/05/2001WO2001047875A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
07/05/2001WO2001047868A1 Novel phenylalanine derivatives
07/05/2001WO2001047558A1 Nerve protective drugs
07/05/2001WO2001009094A3 Chemokine receptor antagonists and methods of use therefor
07/05/2001WO2000050376A3 Efficient synthesis of alkyl carbonates
07/05/2001US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture
07/05/2001CA2395996A1 Neuroprotective drug
07/05/2001CA2395716A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
07/04/2001EP1113014A1 Linear or cyclic ureas, a process for their preparation and pharmaceutical compositions containing them
07/04/2001EP1112262A1 SUBSTITUTED $g(g)-PHENYL-$g(D)-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO
07/04/2001EP1112255A1 4,4-biarylpiperidine derivatives with opioid receptor activity
07/04/2001CN1302184A Composition for keeping away vermin
07/04/2001CN1301699A New direct chain or cyclic urea, its preparing method and medicinal composition containing them
07/04/2001CN1301690A Method for stabilizing N-oxyl compound in vinyl compound
07/04/2001CN1067989C New compound with analgesic and local anaesthetic effect
07/03/2001US6255496 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
07/03/2001US6255325 Chronic, bolus administration of D-threo methylphenidate
07/03/2001US6255322 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
07/03/2001US6255302 Nervous system, psychological disorders